Works matching AU Kobos, Rachel


Results: 32
    1

    Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.

    Published in:
    Oncologist, 2020, v. 25, n. 12, p. e1837, doi. 10.1634/theoncologist.2020-0093
    By:
    • Abou‐Alfa, Ghassan K.;
    • Mayer, Robert;
    • Venook, Alan P.;
    • O'Neill, Allison F.;
    • Beg, Muhammad S.;
    • LaQuaglia, Michael;
    • Kingham, Peter T.;
    • Kobos, Rachel;
    • Basturk, Olca;
    • Brennan, Cameron;
    • Yopp, Adam;
    • Harding, James J.;
    • Leong, Stephen;
    • Crown, John;
    • Hoti, Emir;
    • Leonard, Gregory;
    • Ly, Michele;
    • Bradley, Mikaela;
    • Valentino, Emily;
    • Markowitz, David
    Publication type:
    Article
    2

    A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 925, doi. 10.1634/theoncologist.2020-0367
    By:
    • El Dika, Imane;
    • Mayer, Robert J.;
    • Venook, Alan P.;
    • Capanu, Marinela;
    • LaQuaglia, Michael P.;
    • Kobos, Rachel;
    • O'Neill, Allison F.;
    • Chou, Joanne F.;
    • Ly, Michele;
    • Ang, Celina;
    • O'Reilly, Eileen M.;
    • Gordan, John D.;
    • Abou‐Alfa, Ghassan K.
    Publication type:
    Article
    3

    Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 5, p. 2412, doi. 10.1007/s12325-023-02480-7
    By:
    • Moreau, Philippe;
    • van de Donk, Niels W. C. J.;
    • Delforge, Michel;
    • Einsele, Hermann;
    • De Stefano, Valerio;
    • Perrot, Aurore;
    • Besemer, Britta;
    • Pawlyn, Charlotte;
    • Karlin, Lionel;
    • Manier, Salomon;
    • Leleu, Xavier;
    • Weisel, Katja;
    • Ghilotti, Francesca;
    • Diels, Joris;
    • Elsada, Ahmed;
    • Morano, Raul;
    • Strulev, Vadim;
    • Pei, Lixia;
    • Kobos, Rachel;
    • Smit, Jennifer
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.

    Published in:
    2020
    By:
    • Prockop, Susan;
    • Doubrovina, Ekaterina;
    • Suser, Stephanie;
    • Heller, Glenn;
    • Barker, Juliet;
    • Dahi, Parastoo;
    • Perales, Miguel A.;
    • Papadopoulos, Esperanza;
    • Sauter, Craig;
    • Castro-Malaspina, Hugo;
    • Boulad, Farid;
    • Curran, Kevin J.;
    • Giralt, Sergio;
    • Gyurkocza, Boglarka;
    • Hsu, Katharine C.;
    • Jakubowski, Ann;
    • Hanash, Alan M.;
    • Kernan, Nancy A.;
    • Kobos, Rachel;
    • Koehne, Guenther
    Publication type:
    journal article
    13

    P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972904.51933.45
    By:
    • Frerichs, Kristine;
    • Verkleij, Christie;
    • Mateos, Maria‐Victoria;
    • Zweegman, Sonja;
    • Groen, Kaz;
    • Kuipers, Ilse;
    • Martin, Tom;
    • Rodriguez, Cesar;
    • Nooka, Ajay;
    • Kruijswijk, Sandy;
    • Skerget, Sheri;
    • Doyle, Margaret;
    • Banerjee, Arnob;
    • Chastain, Katherine;
    • Perales‐Puchalt, Alfredo;
    • Stephenson, Tara;
    • Uhlar, Clarissa;
    • Kobos, Rachel;
    • Verona, Raluca;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    14

    P979: PATIENT‐REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL‐WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970820.69075.8f
    By:
    • Moreau, Philippe;
    • van de Donk, Niels W.C.J.;
    • Delforge, Michel;
    • Einsele, Hermann;
    • De Stefano, Valerio;
    • Perrot, Aurore;
    • Besemer, Britta;
    • Pawlyn, Charlotte;
    • Karlin, Lionel;
    • Manier, Salomon;
    • Leleu, Xavier;
    • Thilakarathne, Pushpike;
    • Diels, Joris;
    • Gries, Katharine;
    • Erler‐Yates, Nichola;
    • van Nimwegen, Kirsten;
    • Morano, Raúl;
    • Strulev, Vadim;
    • Haddad, Imene;
    • Kobos, Rachel
    Publication type:
    Article
    15
    16

    Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 8, p. 1861, doi. 10.1080/10428194.2017.1403601
    By:
    • Giulino-Roth, Lisa;
    • O'Donohue, Tara;
    • Boulad, Farid;
    • Trippett, Tanya M.;
    • Klein, Elizabeth;
    • Kernan, Nancy A.;
    • Kobos, Rachel;
    • Prockop, Susan E.;
    • Scaradavou, Andromachi;
    • Shukla, Neerav;
    • Steinherz, Peter G.;
    • Chen, Zhengming;
    • Moskowitz, Alison J.;
    • Moskowitz, Craig H.
    Publication type:
    Article
    17

    Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 5, p. 667, doi. 10.1007/s11523-023-00989-z
    By:
    • Miao, Xin;
    • Wu, Liviawati S.;
    • Lin, Shun Xin Wang;
    • Xu, Yan;
    • Chen, Yang;
    • Iwaki, Yuki;
    • Kobos, Rachel;
    • Stephenson, Tara;
    • Kemmerer, Kristy;
    • Uhlar, Clarissa M.;
    • Banerjee, Arnob;
    • Goldberg, Jenna D.;
    • Trancucci, Danielle;
    • Apte, Amit;
    • Verona, Raluca;
    • Pei, Lixia;
    • Desai, Rachit;
    • Hickey, Kathleen;
    • Su, Yaming;
    • Ouellet, Daniele
    Publication type:
    Article
    18
    19

    Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 13, p. 2035, doi. 10.1002/cncr.34756
    By:
    • Martin, Thomas G.;
    • Mateos, Maria Victoria;
    • Nooka, Ajay;
    • Banerjee, Arnob;
    • Kobos, Rachel;
    • Pei, Lixia;
    • Qi, Ming;
    • Verona, Raluca;
    • Doyle, Margaret;
    • Smit, Jennifer;
    • Sun, Weili;
    • Trancucci, Danielle;
    • Uhlar, Clarissa;
    • van de Donk, Niels W. C. J.;
    • Rodriguez, Cesar
    Publication type:
    Article
    20

    CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia.

    Published in:
    Science Translational Medicine, 2013, v. 5, n. 177, p. 1, doi. 10.1126/scitranslmed.3005930
    By:
    • Brentjens, Renier J.;
    • Davila, Marco L.;
    • Riviere, Isabelle;
    • Park, Jae;
    • Xiuyan Wang;
    • Cowell, Lindsay G.;
    • Bartido, Shirley;
    • Stefanski, Jolanta;
    • Taylor, Clare;
    • Olszewska, Malgorzata;
    • Borquez-Ojeda, Oriana;
    • Jinrong Qu;
    • Wasielewska, Teresa;
    • Qing He;
    • Bernal, Yvette;
    • Rijo, Ivelise V.;
    • Hedvat, Cyrus;
    • Kobos, Rachel;
    • Curran, Kevin;
    • Steinherz, Peter
    Publication type:
    Article
    21

    Teclistamab: Mechanism of action, clinical, and translational science.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 1, p. 1, doi. 10.1111/cts.13717
    By:
    • Guo, Yue;
    • Quijano Cardé, Natalia A.;
    • Kang, Lijuan;
    • Verona, Raluca;
    • Banerjee, Arnob;
    • Kobos, Rachel;
    • Chastain, Katherine;
    • Uhlar, Clarissa;
    • Pillarisetti, Kodandaram;
    • Doyle, Margaret;
    • Smit, Jennifer;
    • Haddish‐Berhane, Nahor;
    • Ouellet, Daniele
    Publication type:
    Article
    22
    23

    Paroxysmal nocturnal hemoglobinuria in pediatric patients.

    Published in:
    Pediatric Blood & Cancer, 2012, v. 59, n. 3, p. 525, doi. 10.1002/pbc.23410
    By:
    • Curran, Kevin J.;
    • Kernan, Nancy A.;
    • Prockop, Susan E.;
    • Scaradavou, Andromachi;
    • Small, Trudy N.;
    • Kobos, Rachel;
    • Castro-Malaspina, Hugo;
    • Araten, David;
    • DiMichele, Donna;
    • O'Reilly, Richard J.;
    • Boulad, Farid
    Publication type:
    Article
    24
    25
    26
    27

    Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen–matched or –mismatched donors.

    Published in:
    Pediatric Hematology & Oncology, 2016, v. 33, n. 6, p. 347, doi. 10.1080/08880018.2016.1204399
    By:
    • Mussetti, Alberto;
    • Kernan, Nancy A.;
    • Prockop, Susan E;
    • Scaradavou, Andromachi;
    • Lehrman, Rachel;
    • Ruggiero, Julianne M;
    • Curran, Kevin;
    • Kobos, Rachel;
    • O'Reilly, Richard;
    • Boulad, Farid
    Publication type:
    Article
    28

    Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 194, doi. 10.1016/j.clml.2023.11.001
    By:
    • Martin, Thomas G.;
    • Moreau, Philippe;
    • Usmani, Saad Z.;
    • Garfall, Alfred;
    • Mateos, Maria-Victoria;
    • San-Miguel, Jesus F.;
    • Oriol, Albert;
    • Nooka, Ajay K.;
    • Rosinol, Laura;
    • Chari, Ajai;
    • Karlin, Lionel;
    • Krishnan, Amrita;
    • Bahlis, Nizar;
    • Popat, Rakesh;
    • Besemer, Britta;
    • Martfnez-Lopez, Joaquin;
    • Delforge, Michel;
    • Trancucci, Danielle;
    • Pei, Lixia;
    • Kobos, Rachel
    Publication type:
    Article
    29

    Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 385, doi. 10.1016/j.clml.2023.02.006
    By:
    • Mateos, María-Victoria;
    • Chari, Ajai;
    • Usmani, Saad Z.;
    • Goldschmidt, Hartmut;
    • Weisel, Katja;
    • Qi, Keqin;
    • Londhe, Anil;
    • Nair, Sandhya;
    • Lin, Xiwu;
    • Pei, Lixia;
    • Ammann, Eric;
    • Kobos, Rachel;
    • Smit, Jennifer;
    • Parekh, Trilok;
    • Marshall, Alexander;
    • Slavcev, Mary;
    • Moreau, Philippe
    Publication type:
    Article
    30
    31
    32

    Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

    Published in:
    Journal of Pathology, 2013, v. 229, n. 5, p. 743, doi. 10.1002/path.4158
    By:
    • Kobos, Rachel;
    • Nagai, Makoto;
    • Tsuda, Masumi;
    • Merl, Man Yee;
    • Saito, Tsuyoshi;
    • Laé, Marick;
    • Mo, Qianxing;
    • Olshen, Adam;
    • Lianoglou, Steven;
    • Leslie, Christina;
    • Ostrovnaya, Irina;
    • Antczak, Christophe;
    • Djaballah, Hakim;
    • Ladanyi, Marc
    Publication type:
    Article